Information  X 
Enter a valid email address

Lekoil Limited (LEK)


Monday 27 June, 2022

Lekoil Limited

Litigation update

RNS Number : 2031Q
Lekoil Limited
27 June 2022




27 June 2022

Lekoil Limited

("LEKOIL" or the "Company")


Litigation update


LEKOIL (AQSE: LEK), the Cayman Islands litigation asset company with an investment in oil & gas assets in Nigeria, provides the following update in respect of the claim by Mr Akinyanmi, in the Cayman Islands, seeking a declaration (amongst others) that the Share Allotment Resolutions passed at the Company's AGM on 21 December 2021 were ultra vires and void. 


Mr Akinyanmi has applied to the Court to: (i) add Lekoil Nigeria as a Plaintiff; (ii) add the parties to the Convertible Facilities Agreements as Defendants; and (iii) for certain ancillary orders and directions necessary to give effect to (i) and (ii).  The Court has consented to Mr Akinyanmi's application. 



The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.


For further information, please visit or contact:

First Sentinel Corporate Finance Ltd (AQSE Corporate Adviser)

Brian Stockbridge


+44 203 989 2200

Tennyson Securities (Broker)

Peter Krens

+44 20 7186 9030

Camarco (Financial PR Advisor)

Billy Clegg / Owen Roberts / Violet Wilson

+44 20 3757 4983


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t